This is what's been around in the last a few weeks, which kept the stock down - even though jbog had been trying hard to find other reasons. I even have people who are concerned about my MNTA position emailed me about rumor Teva's generic Lovenox is going to be approved in a month. I think MNTA's current stock price priced Teva's generic approval soon, which I doubt anyone knows for sure.